Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes
暂无分享,去创建一个
Marina Scavini | Antonio Ceriello | Antonio Tiengo | D. Cucinotta | A. Tiengo | F. Giorgino | E. Bosi | A. Ceriello | Emanuele Bosi | Domenico Cucinotta | Francesco Giorgino | M. Scavini | Raffaele Marino | Erminio Bonizzoni | Raffaele Marino | E. Bonizzoni
[1] Belgium.,et al. Global guideline for type 2 diabetes. , 2014, Diabetes research and clinical practice.
[2] R. Rubin,et al. Structure and Correlates of Diabetes-Specific Locus of Control , 1994, Diabetes Care.
[3] B P Kovatchev,et al. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. , 1998, Diabetes care.
[4] Stephan Martin,et al. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. , 2010, Diabetes Technology & Therapeutics.
[5] Elizabeth Goyder,et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial , 2007, BMJ : British Medical Journal.
[6] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. , 2005, The Cochrane database of systematic reviews.
[7] I. Shimomura,et al. Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy. , 2010, Diabetes Research and Clinical Practice.
[8] R. I. Harris,et al. Statistical handling of drop-outs in longitudinal clinical trials. , 1993, Statistics in Medicine.
[9] L. Welschen,et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. , 2012, The Cochrane database of systematic reviews.
[10] A. Nicolucci,et al. Four‐year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD‐Annals initiative , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[11] D. Cucinotta,et al. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention , 2011, Acta Diabetologica.
[12] D. Hinnen,et al. Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes. , 2012, Diabetes research and clinical practice.
[13] W. Ambrosius,et al. Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial , 2010, Diabetes Care.
[14] M. Porta,et al. A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. , 2004, Diabetes care.
[15] P. Cryer. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes , 2007, Diabetes Care.
[16] Darrell M. Wilson,et al. Consensus Report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose , 2008, Journal of diabetes science and technology.
[17] M. O'Kane,et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial , 2008, BMJ : British Medical Journal.
[18] Christopher G Parkin,et al. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. , 2011, Diabetes technology & therapeutics.
[19] A. Calle-Pascual,et al. Benefits of self‐monitoring blood glucose in the management of new‐onset Type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic‐based interventional study with parallel groups , 2010, Journal of diabetes.
[20] M. Davidson,et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. , 2005, The American journal of medicine.
[21] Y. Jang,et al. Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .
[22] P. Cryer. Death during intensive glycemic therapy of diabetes: mechanisms and implications. , 2011, The American journal of medicine.
[23] M. Trovati,et al. Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin. , 2010, Diabetes research and clinical practice.
[24] W. Polonsky,et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes , 2011, Diabetes Care.
[25] W. Polonsky,et al. The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes , 2011, Current medical research and opinion.
[26] G. Sartore,et al. ROSES: role of self‐monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[27] V. Basevi,et al. Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.
[28] Daniel J Cox,et al. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. , 2003, Diabetes technology & therapeutics.
[29] C. Viscoli,et al. Lower Baseline Glycemia Reduces Apparent Oral Agent Glucose-Lowering Efficacy , 2006, Diabetes Care.
[30] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[31] Daniel J Cox,et al. Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. , 2002, Diabetes technology & therapeutics.
[32] G. Nichols,et al. Slow response to loss of glycemic control in type 2 diabetes mellitus. , 2003, The American journal of managed care.
[33] Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT) , 1988, Diabetes Care.
[34] G. Nijpels,et al. Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients , 2012, Diabetes Care.
[35] J. Wofford. Clinical inertia. , 2002, Annals of internal medicine.
[36] Martin Straume,et al. Risk Analysis of Blood Glucose Data: A Quantitative Approach to Optimizing the Control of Insulin Dependent Diabetes , 2000 .
[37] J. Lasalle,et al. Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management , 2010, International journal of clinical practice.
[38] M. Porta,et al. The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care , 2008, Diabetic medicine : a journal of the British Diabetic Association.